Personalized Medicine Coalition Conference​ (PMC 2024)

Molecular Tumor Board: 75-year-old male presents with a several month history of a painful tongue lesion and weight loss

In this Molecular Tumor Board we review cases of oral cavity squamous cell carcinoma and explore the clinical utility of lymphatic fluid collected from surgical drains as a novel source of ctDNA. This innovative approach from Droplet Biosciences offers potential for more precision monitoring and personalized treatment strategies. 

Presented by:

Wendy Winckler, PhD
Chief Science Officer
Droplet Biosciences

Jose Zevallos, MD, MPH
Scientific Co-founder
Droplet Biosciences

Labcorp Perspectives: Oncology | Innovations in oncology: Highlights from ASCO's annual meeting (Episode 3)

The latest episode of Labcorp Perspectives: Oncology featuring Dr. Rebecca Previs, director of medical affairs at Labcorp Oncology, and Dr. Eric Severson, executive director of medical affairs at Labcorp, share notable insights from the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. They explore the role of liquid biopsies in cancer diagnostics, specifically Labcorp's Plasma Complete™ test, a noninvasive alternative to traditional biopsies.

Biomarkers of Immunotherapy Response: Current State-of-the-Art and Emerging Trends

Graphical Summary: Real-world comprehensive genomic and immune profiling in non-small cell lung cancer (NSCLC)

Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer

Molecular Tumor Board: 56-year-old with endometrial cancer and POLE V411L alteration

Uterine cancer is the most common gynecologic cancer in the US, with increasing incidence and mortality rate. This Molecular Tumor Board case presented is about a 56-year-old female patient with uterine cancer and an underlying POLE V411L alteration. Join us as we discuss molecular subgroups in uterine cancer and how molecular classification impacts targeted therapy options.

ACMG 2024: From screening to diagnostic solutions: Comprehensive testing for women's health and wellness

Graphical Summary: Cancer-testis antigen burden (CTAB): A novel biomarker of tumor-associated antigens in lung cancer